IMGENEX India’s major objective is to develop research reagents to facilitate research in critical areas of health and diseases. Scientists at IMGENEX India carry out research projects in the areas of osteoporosis, cancer and stem cells and inflammatory diseases either independently or in collaboration with national and international institutions. These research projects are funded indigenously as well as by national funding agencies.
IMGENEX India has several projects undergoing in its R&D laboratory. We are investigating to develop a peptide based therapy for osteoporosis in collaboration with Institute of Life Sciences (ILS), Bhubaneswar under SIBRI scheme of Department of Biotechnology (DBT), Ministry of Science & Technology, Government of India.
IMGENEX India is also studying the potential of a plant based medicine for cancer which is funded by National Medicinal Plants Board (NMPB), Department of AYUSH, Ministry of Health and Family Welfare, Government of India and in collaboration with Regional Plant Resource Center (RPRC), Bhubaneswar.
Two important research projects, role of TLRs in adaptive immunity especially on T cell immunity and development of potential iron based drug for cancer are under progress in collaboration with National Institute of Science Education and Research (NISER), Bhubaneswar and funded by DBT.
Research on generation of induced pluripotent stem (iPS) cells from adult somatic cells using non-genomic protein transduction method is currently a major project going on at IMGENEX India under SIBRI scheme of DBT.
Similarly a joint project with All India Institute of Medical Sciences (AIIMS), New Delhi and York University, Toronto, Canada and Xphase Pharmaceuticals Inc., Toronto, Canada is under progress to develop head and neck cancer markers with an aim to develop diagnostic array.
Currently we are focusing on another DBT funded project on the development of a biosimilar drug under BIPP scheme of DBT for the development of high expression plasmid vectors for the production of biosimilar, herceptin.
Recently we have developed of diagnostic kit to detect the mutations in common Indian beta-thalassemia for human. This project was in collaboration with National Institute Immunohematology, Mumbai and funded by Indian Council for Medical Research (ICMR), New Delhi.
Recently IMGENEX India is working on a research project to develop detection kit for plant viruses in collaboration with Indian Agricultural Research Institute, New Delhi and funded by BIRAC.